Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2013
07/10/2013CN101130526B Aryl carbonyl derivatives as therapeutic agents
07/09/2013US8481785 Materials for N-doping the electron-transporting layers in organic electronic components
07/09/2013US8481576 Guanidine compounds, and use thereof as binding partners for 5-HT5 receptors
07/09/2013US8481575 Synthesis of epothilones, intermediates thereto, analogues and uses thereof
07/09/2013US8481574 Compounds as cannabinoid receptor ligands
07/09/2013US8481536 Benzotriazine inhibitors of kinases
07/09/2013US8481524 c-MET protein kinase inhibitors
07/09/2013CA2761440C Fredericamycin derivatives
07/09/2013CA2558600C A substituted-trialkyl amine compound with anti-viral activity based on antagonism against a chemokine receptor cxcr4
07/09/2013CA2556917C Process for preparing macrocyclic compounds
07/09/2013CA2516407C Heteroarylcarbamoylbenzene derivatives
07/04/2013WO2013101954A1 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors
07/04/2013WO2013101830A1 2 - benzyl, 3 - (pyrimidin- 2 -yl) substituted pyrazoles useful as sgc stimulators
07/04/2013WO2013100632A1 THIENO[3,2-d]PYRIMIDINE DERIVATIVES HAVING INHIBITORY ACTIVITY FOR PROTEIN KINASES
07/04/2013WO2013100418A1 Method of extracting and purifying epothilone a and b from an epothilone-containing material
07/04/2013WO2013098375A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013WO2013098373A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013WO2013098146A1 Fungicidal 3-[(1,3-thiazol-4-ylmethoxyimino)(phenyl)methyl]-2-substituted-1,2,4-oxadiazol-5(2h)-one derivatives
07/04/2013WO2013098145A1 Quinuclidine esters of 1-azaheterocyclylacetic acid as antimuscarinic agents, process for their preparation and medicinal compositions thereof
07/04/2013WO2013097947A1 Pipecolate-sulfonamides for treatment of psychiatric disorders
07/04/2013WO2013097224A1 Fused tricyclic compounds as raf kinase inhibitors
07/04/2013WO2013055949A3 Pyrazol-3-ones that activate pro-apoptotic bax
07/04/2013US20130172550 P2x4 receptor antagonist
07/04/2013US20130172365 Arylosulfonamides for the treatment of cns diseases
07/04/2013US20130172353 3-phenyl-5-ureidoisothiazole-4-carboximide and 3-amino-5-phenylisothiazole derivatives as kinase inhibitors
07/04/2013US20130172351 Dihydropyrazoles
07/04/2013US20130172349 Inhibitors of phosphatidylinositol 3-kinase
07/04/2013US20130172344 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
07/04/2013US20130172341 Fused pyrazole derivatives as novel erk inhibitors
07/04/2013US20130172339 Sulfonamide compounds
07/04/2013US20130172327 Substituted n- [1-cyano-2- (phenyl) ethyl] -2-azabicyclo [2.2.1] heptane-3-carboxamide inhibitors of cathepsin c
07/04/2013US20130172326 Derivatives of heteroarylsulfonamides, their preparation and their application in human therapy
07/04/2013US20130172323 Pyridazinones as gpr119 agonists
07/04/2013US20130172317 Triazine derivative and pharmaceutical composition having an analgesic activity comprising the same
07/04/2013US20130172316 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013US20130172315 Substituted anilines as ccr(4) antagonists
07/04/2013US20130172312 Azetidine Derivatives
07/04/2013CA2861013A1 New azetidine derivatives, pharmaceutical compositions and uses thereof
07/04/2013CA2856347A1 Fused tricyclic compounds as raf kinase inhibitors
07/03/2013EP2610244A1 Indole compounds
07/03/2013EP2609095A2 Compounds that modulate intracellular calcium
07/03/2013EP2609094A1 Heteroarylpiperidine and -piperazine derivatives as fungicides
07/03/2013EP2609092A1 Oxadiazole inhibitors of leukotriene production
07/03/2013EP2609091A1 Pharmaceutically active compounds as axl inhibitors
07/03/2013EP2609081A1 Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes
07/03/2013EP2608671A1 Compounds for treatment of cancer
07/03/2013CN103189370A Triazole derivatives as ligands for GABA receptors
07/03/2013CN103189363A Bisaryl-bonded aryltriazolones and use thereof
07/03/2013CN103183669A Thiazole methylaminopyridine compounds and preparation method for same
07/03/2013CN103183659A Chromane derivative used as TRPV3 (transient receptor potential vanillin 3) regulator
07/03/2013CN101970418B Pyrazine derivative and its uses as protein kinase inhibitor
07/03/2013CN101678007B Gonadotropin-releasing hormone receptor antagonists and its pharmaceutical application
07/02/2013US8476450 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
07/02/2013US8476449 Radioactive iodine labeled organic compound or salt thereof
07/02/2013US8476437 Process for preparation of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine and new impurities in preparation thereof
07/02/2013US8476302 α-ketoamide derivatives useful endothelial lipase inhibitors
07/02/2013US8476287 3-hydroxy-5-arylisothiazole derivative
07/02/2013US8476286 Quinazoline derivatives which promote the release of parathyroid hormone
07/02/2013US8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
07/02/2013US8476278 Thiazole Derivatives as protein kinase inhibitors
07/02/2013US8476277 TRPV1 antagonists including dihydroxy substituent and uses thereof
07/02/2013US8476268 Pyrrolidine-1,2-dicarboxamide derivatives
07/02/2013US8476264 N-(3-(2-amino-6,6-difluoro-4,4A,5,6,7,7A-hexahydro-cyclopenta[E][1,3]oxazin-4-yl)-phenylamides as BACE1 inhibitors
07/02/2013US8476257 Viral polymerase inhibitors
07/02/2013CA2657469C Novel aminopyridine derivatives having aurora a selective inhibitory action
07/02/2013CA2470964C Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
06/2013
06/27/2013WO2013096971A1 Asymmetric electrophilic fluorination using an anionic chiral phase-transfer catalyst
06/27/2013WO2013096060A1 Compounds for inhibiting the interaction of bcl2 with binding partners
06/27/2013WO2013095275A1 Novel hepatitis c virus inhibitors
06/27/2013WO2013094761A1 Novel s1p receptor modulator
06/27/2013WO2013093842A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
06/27/2013WO2013092976A1 New piperidine derivatives, pharmaceutical compositions and uses thereof
06/27/2013WO2013092943A1 Isothiazoline compounds for combating invertebrate pests
06/27/2013WO2013092893A1 Chemical compounds
06/27/2013WO2013092711A1 Trpm8 antagonists
06/27/2013WO2013092616A1 New aziridine compounds, pharmaceutical compositions and their use as acetyl-coa carboxylase inhibitors
06/27/2013WO2013091011A1 Heterocyclic urea compounds
06/27/2013US20130165489 Small Molecule Modulators of HIV-1 Capsid Stability and Methods Thereof
06/27/2013US20130165485 Insecticidal compounds
06/27/2013US20130165483 Heteroaryls and uses thereof
06/27/2013US20130165460 Sulfur derivatives as chemokine receptor modulators
06/27/2013US20130165451 Compounds for inflammation and immune-related uses
06/27/2013US20130165450 Novel Thiazol-Carboximide Derivatives as PDK1 Inhibitors
06/27/2013US20130165446 Benzo-or pyrido-imidazole derivative
06/27/2013US20130165444 Piperidine Derivatives
06/27/2013US20130165443 Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonists
06/27/2013US20130165442 Modulators of ATP-Binding Cassette Transporters
06/27/2013US20130165440 JAK1 Inhibitors
06/27/2013US20130165438 Prostaglandin d synthase inhibitory piperidine compounds
06/27/2013US20130165432 Dual Modulators of 5HT2A and D3 Receptors
06/27/2013US20130165431 Inhibitors of syk and jak protein kinases
06/27/2013US20130165422 Hexafluoroisopropyl carbamate derivatives, their preparation and their therapeutic application
06/27/2013US20130165416 Compounds and uses thereof in modulating levels of various amyloid beta peptide alloforms
06/27/2013US20130164259 1,4-substituted piperazine derivatives and methods of use thereof
06/27/2013US20130164218 Hypoxia inducible factor-1 pathway inhibitors and uses as anticancer and imaging agents
06/27/2013CA2858328A1 Heterocyclyl derivatives and their use as prostaglandin d2 receptor modulators
06/26/2013EP2607357A1 Benzothiazoles as ghrelin receptor modulators
06/26/2013EP2606889A1 Substituted Thiazoles as VEGFR2 kinase Inhibitors
06/26/2013EP2606888A1 Trpm8 antagonists
06/26/2013EP2606727A1 Compounds with nematicidal activity
1 ... 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 ... 628